CompletedNot Applicable

ALFApump System Post Marketing Surveillance Registry

Germany100 participantsStarted 2012-06

Plain-language summary

This is a post market surveillance registry to monitor the safety and performance of the ALFApump system.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Refractory or recurrent ascites and liver cirrhosis or malignancy * written informed consent Exclusion Criteria: * \< 18 years * pregnant * not able to use the Smart charger

What they're measuring

Safety

Timeframe: 24 months

Trial details

NCT IDNCT01532427

SponsorSequana Medical N.V.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2019-07-08

View on ClinicalTrials.gov More Liver Cirrhosis trials